Gene knockout experiments demonstrated that UBAP2L inhibition could impede cell proliferation and lead to cell cycle arrest at the G2/M phase, suggesting UBAP2L is a potential target for breast cancer treatment [19]. Here, UBAP2L is linked to breast cancer.